Vaccines (predominantly mRNA vaccines) have been our front-line defense against COVID and have saved millions of lives.
Sep 26, 2022
0
16
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of vaccine ...
Nov 6, 2021
5
268
As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially omicron, have developed ways to evade the antibodies we make in response ...
Aug 11, 2022
0
170
A Brazilian study published in the journal PNAS describes some of the effects infection by SARS-CoV-2 can have on the central nervous system. A preliminary version (not yet peer-reviewed) posted in 2020 was one of the first ...
Oct 1, 2022
0
670
A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
Sep 22, 2022
0
130
Mutations to the spike protein of the omicron variant are shown to alter how the virus infects cells and reduce its sensitivity to therapeutic and vaccine-elicited antibodies, according to a paper published in Nature. Booster ...
Feb 3, 2022
0
35
At-home rapid COVID-19 tests are getting harder to find leading up to the Christmas holiday. Adding to the confusion, new preliminary information that suggests some rapid tests may not be able to detect the omicron variant, ...
Dec 21, 2021
0
28
A team co-led by scientists at Scripps Research has found evidence that a compound contained in the medicinal and culinary herb rosemary could be a two-pronged weapon against the SARS-CoV-2 coronavirus that causes COVID-19.
Feb 1, 2022
0
1099
It is controversial whether viruses are alive, but—like all living things—they do evolve. This fact has become abundantly clear during the pandemic, as new variants of concern have emerged every few months.
Dec 23, 2021
0
37
Scientists at La Jolla Institute for Immunology (LJI) have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. Their in-depth look at how T cells, B cells, antibody levels ...
May 31, 2022
1
148
